<DOC>
	<DOCNO>NCT01960647</DOCNO>
	<brief_summary>The primary objective prospective , Randomized , Controlled , Multicentre , Open Study investigate inhibition restenosis Paclitaxel-eluting Percutaneous transluminal angioplasty ( PTA ) balloon Freeway versus PTA alone treatment de-novo occlude , stenotic reoccluded , restenotic superficial femoral ( SFA ) popliteal artery .</brief_summary>
	<brief_title>FREERIDE STUDY , Freeway Paclitaxel Coated Balloon Catheter Treat Peripheral Artery Disease</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Male nonpregnant female ( &gt; 18 year age ) symptomatic ischemia , require treatment SFA PI segment ( 25 Rutherford classification ) Single and/or multiple de novo occlude , stenotic reoccluded , restenotic lesion ( ) &gt; 70 % , ≤ 15 cm total length vessel diameter ≥ 4mm ≤ 7mm ( visual estimation ) . Patient provide sign informed consent complies follow visit Successful wire cross lesion At least one patent ( le 50 % stenosis ) tibioperoneal runoff vessel Gastrointestinal bleed coagulopathy contraindicating use antiplatelet therapy Known intolerance contraindication study medication contrast agent , noncontrollable medication . Patient actively participate another device drug study History hemorrhagic stroke within 3 month Previous plan surgical intervention procedure within 30 day index procedure Significant untreated inflow disease normal arterial segment proximal lesion duplex ultrasound velocity ratio measure Acute subacute thrombus target vessel Use adjunctive therapy ( i.e . laser , atherectomy , cryoplasty , scoring/cutting balloon ) Patients instent restenosis prior surgery target lesion Patients abdominal aortic , iliaca popliteal aneurysm ( AAA ) ≥ 4cm diameter</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>